Year archive

Guangzhou Innogen Pharmaceutical Group Co., Ltd. — 2025 filings

All 33 regulatory filings released by Guangzhou Innogen Pharmaceutical Group Co., Ltd. (2591) in 2025, sourced directly from the official regulator.

33 Filings

2025 Period

2025 filings (33)

Filing	Released	Lang
Articles of Association Governance Information	2025-12-17	English
AMENDMENTS TO THE ARTICLES OF ASSOCIATION Regulatory Filings	2025-12-17	English
VOLUNTARY ANNOUNCEMENT - INCLUSION IN THE STOCK LIST OF THE SHANGHAI-HONG KONG STOCK CONNECT AND THE SHENZHEN-HONG KONG STOCK CONNECT Regulatory Filings	2025-12-08	English
VOLUNTARY ANNOUNCEMENT - INCLUSION OF THE COMPANY'S CORE PRODUCT IN THE NATIONAL REIMBURSEMENT DRUG LIST Regulatory Filings	2025-12-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-03	English
DISCLOSEABLE TRANSACTION IN RELATION TO SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS Regulatory Filings	2025-12-01	English
ANNOUNCEMENT REGARDING THE POSTPONEMENT OF THE RE-ELECTION OF THE BOARD AND THE SUPERVISORY COMMITTEE Regulatory Filings	2025-11-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-05	English
DISCLOSEABLE TRANSACTION IN RELATION TO SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS Regulatory Filings	2025-11-03	English
DISCLOSEABLE TRANSACTIONS IN RELATION TO SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS Regulatory Filings	2025-10-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-08	English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON CLINICAL TRIAL OF CORE PRODUCT IN THE PRC Regulatory Filings	2025-09-30	English
Interim Report 2025 Interim / Quarterly Report H1 2025	2025-09-29	English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON COMMERCIALISATION OF CORE PRODUCT IN MACAU Regulatory Filings	2025-09-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-04	English
DISCLOSEABLE TRANSACTIONS IN RELATION TO SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS; AND NON-COMPLIANCE OF LISTING RULES Regulatory Filings	2025-09-01	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H2 2025	2025-08-29	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON CLINICAL TRIAL OF CORE PRODUCT IN AUSTRALIA Regulatory Filings	2025-08-26	English
NOTICE OF BOARD MEETING Report Publication Announcement	2025-08-19	English
ANNOUNCEMENT OF ALLOTMENT RESULTS Share Issue/Capital Change	2025-08-14	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-08-14	English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-08-14	English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-08-14	English
TERMS OF REFERENCE OF THE REMUNERATION AND APPRAISAL COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2025-08-14	English
Articles of Association Governance Information	2025-08-14	English
Documents on Display Regulatory Filings	2025-08-07	English
GLOBAL OFFERING Share Issue/Capital Change	2025-08-07	English
GLOBAL OFFERING Share Issue/Capital Change	2025-08-07	English
PHIP (1st submission) Regulatory Filings	2025-07-31	English
PHIP (1st submission) Audit Report / Information FY 2024	2025-07-31	English
OC Announcement - Appointment Regulatory Filings	2025-06-09	English
Application Proof (1st submission) Audit Report / Information FY 2024	2025-06-09	English
Application Proof (1st submission) Regulatory Filings	2025-06-09	English